Description
THERAPUETIC APHERESIS
First action · last action
2010-05-17 · 2012-05-23
Transactions
3
First transaction's obligation
$45,000
Base + all options value (sum of deltas)
$81,012
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA262P0879
NAICS
621399 · OFFICES OF ALL OTHER MISCELLANEOUS HEALTH PRACTITIONERS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-05-17+$45,000= $45,000
- Mod P000022012-05-07-$3,988= $41,012
- Mod P000012012-05-23+$40,000= $81,012
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-05-17 | +$45,000 | $45,000 | THERAPUETIC APHERESIS |
| Mod P00002· FUNDING ONLY ACTION | 2012-05-07 | −$3,988 | $41,012 | THERAPUETIC APHERESIS |
| Mod P00001· FUNDING ONLY ACTION | 2012-05-23 | +$40,000 | $81,012 | THERAPUETIC APHERESIS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KLXGB46K7SL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26223C0045 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q508 · HEMATOLOGY & ONCOLOGY | $219,282 | FY2023 |
| 36C26221C0142 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q508 · HEMATOLOGY & ONCOLOGY | $62,240 | FY2021 |
| 36C26221N0664 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $238,752 | FY2021 |
| 36C26220N0976 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $232,397 | FY2020 |
| 36C26220N0927 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $378,225 | FY2020 |
| 36C26220N0912 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $530,588 | FY2020 |
Other recipients under Q515 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26215J4012 | LOMA LINDA UNIVERSITY MEDICAL CENTER | 262-NETWORK CONTRACT OFFICE 22 | $63,450 | FY2015 |
| VA26214P6955 | CONSULTANTS FOR PATHOLOGY AND LABORATORY MEDICINE A MEDICAL GROUP INC | 262-NETWORK CONTRACT OFFICE 22 | $39,000 | FY2014 |
| VA26214P6315 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 262-NETWORK CONTRACT OFFICE 22 | $10,000 | FY2014 |
| VA26214P6323 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 262-NETWORK CONTRACT OFFICE 22 | $8,733 | FY2014 |
| VA26214P6251 | SEAHORSE BIOSCIENCE, INC. | 262-NETWORK CONTRACT OFFICE 22 | $13,060 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA605C06006_3600_VA262P0879_3600 · retrieved 2026-09-26.